Purchase Order 75N98019P02629

<p>The National Heart Lung and Blood Institute awarded a purchase order to Covaris, LLC for a Covaris LE220-PLUS Focused-Ultrasonicator (E220 upgrade) valued at $52,580 with an award date of August 28, 2018. Performance is located in Woburn, Massachusetts. The order carries a firm fixed price structure with an ultimate completion date of October 12, 2018. The underlying solicitation was posted July 23, 2018 with a due date of July 30, 2018.</p>

<p>The National Cancer Institute awarded a purchase order to Covaris, LLC for a Covaris ME220 Focused Ultrasonicator for Chromatin and DNA Shearing valued at $55,513.00 on August 7, 2019. The order carries a Total Small Business set-aside designation. Performance occurs at Woburn, Massachusetts. The underlying solicitation was posted July 5, 2019, with a due date of July 12, 2019. Ultimate completion is scheduled for October 2, 2019. The contract is firm fixed price.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Covaris, LLC for a Covaris equipment ultrasonicator with a ceiling value of $54,858.40 on November 20, 2018. Performance is located in Woburn, Massachusetts. The order is firm fixed price with an ultimate completion date of December 21, 2018.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a firm fixed-price purchase order contract to Covaris, Inc., a for-profit limited liability company, for the acquisition of an E220 Focused UltraSonicator with water conditioning system and chiller. The total potential value of the contract is $120,935.00. The contract did not have a set-aside designation. According to the pre-solicitation notice, the Covaris E220...

This is a $89,747.51 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Covaris, LLC for the delivery of a /E220 FOCUSED-ULTRASONICATOR SYSTEM. The contract has no set-aside designation. Covaris, LLC is a for-profit manufacturer of advanced genomic research tools and technologies, including the Adaptive Focused Acoustics (AFA) ultrasonicator instruments supplied under this award. The ultrasonicator...

This is a $47,300.00 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Covaris, LLC, a for-profit manufacturer of advanced genomic research equipment and accessories. The contract is for the delivery of Covaris' desktop focused-ultrasonicator instruments, such as the ME220, M220, and LE220-plus models, as well as related maintenance services. This award does not have...

Covaris, LLC was awarded a firm fixed-price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences for the delivery of a Covaris R230 Focused-Ultrasonicator. With a potential value of $125,580, this sole source contract has no set aside designation and calls for the prime contractor to provide the specified equipment to the agency by May 3, 2024. As the industry leader in tools and technologies for DNA and RNA shearing and other genomic...

This firm-fixed-price purchase order valued at $4,500 was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Covaris, LLC, a for-profit manufacturer of advanced genomic sample preparation instruments and accessories. The contract, which had no set-aside designation, was for the delivery of Covaris' ME220, M220, and LE220-plus focused-ultrasonicator systems and related maintenance services to support genomic...

<p>The National Cancer Institute awarded a purchase order to Covaris, LLC for one E220 focused-ultrasonicator instrument valued at $132,195.00 on August 22, 2017. This is a Total Small Business set-aside, firm fixed-price acquisition. The ultrasonicator is procured for sample preparation and analysis at the National Cancer Institute facility in Rockville, Maryland. The order carries an ultimate completion date of October 17, 2017.</p>

This firm-fixed-price purchase order contract was awarded to Covaris, LLC, a for-profit manufacturer of advanced genomics tools and technologies, by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The contract, valued at $28,185.00, is for the upgrade of ultrasonicator systems used to support NIAID's genomic research initiatives. Covaris, which has extensive experience providing equipment and maintenance services to...